Rubella seroprevalence using residual samples from the South African measles surveillance program: a cross-sectional analytic study

被引:3
作者
Motaze, N. V. [1 ,2 ]
Makhathini, L. [1 ]
Smit, S. B. [1 ]
Adu-Gyamfi, C. G. [1 ,3 ]
Fortuin, M. [1 ]
Wiysonge, C. S. [2 ,4 ]
Suchard, S. M. [1 ,3 ]
机构
[1] Natl Inst Communicable Dis, Ctr Vaccines & Immunol, Natl Hlth Lab Serv, Div A, Johannesburg, South Africa
[2] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Global Hlth, Stellenbosch, South Africa
[3] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Chem Pathol, Johannesburg, South Africa
[4] South African Med Res Council, Cochrane South Africa, Cape Town, South Africa
关键词
Rubella; serosurvey; immunity; antibodies; sero-epidemiology; rubella-containing vaccines; seroprevalence; INFECTION;
D O I
10.1080/21645515.2020.1738834
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Introduction: South Africa is yet to introduce rubella-containing vaccines (RCV) into its routine immunization schedule. Selecting the target population when introducing RCV should take into account the ages of susceptible individuals in the population. We aimed to determine the seroprevalence of antibodies to rubella and characterize immunity gaps among individuals of all ages in South Africa. Methods: We tested for rubella immunoglobulin G (IgG) antibodies with a commercial enzyme-linked immunosorbent assay. We used residual samples collected from 2016 through 2018 as part of the national measles surveillance program. We only tested samples that were negative for measles and rubella immunoglobulin M (IgM) and explored the association between rubella susceptibility (IgG negative) and predictor variables (year of sample collection, age, sex, and province of residence) using logistic regression analysis. Results: We obtained results for 6057 records. Rubella susceptibility was highest among Individuals aged zero to 11 months (81.9%), followed by children 1 to 5 years old (71.5%), 6 to 10 y old (40.9%) and 11 to 15 y old (31.25) while the smallest proportion of susceptible individuals was among those 16 to 49 y old (19.9%). Females were less likely to be susceptible to rubella compared to males (OR = 0.79 (95%CI: 0.71-0.87), P < .001) in unadjusted analysis but this effect was not observed after adjusting for age and province. In multivariable logistic regression, age (OR = 6.24 (4.52-8.63), P < .001) and province of residence (OR = 0.97 (95%CI: 0.95-0.99), P = .01) were associated with rubella susceptibility. Conclusion: In the absence of rubella vaccination in the Expanded Program on Immunization in South Africa, the bulk of individuals susceptible to rubella are children under 16 y old. About 20% of individuals 16 to 49 y old are susceptible to rubella. This susceptibility gap must be born in mind during RCV introduction.
引用
收藏
页码:2656 / 2662
页数:7
相关论文
共 50 条
  • [11] Measles and Rubella Seroprevalence Among Children and Adolescents of Cordoba, Argentina: A Cross-Section Study in the Context of the Elimination Program
    Pedranti, Mauro
    Isa, Maria Beatriz
    Riberi, Maria Ines
    Hernandez, Gabriela
    Alfaro, Jimena
    Tenaglia, Magdalena
    Salbetti, Maria Belen Colazo
    Mladin, Juan Javier
    Nates, Silvia
    Adamo, Maria Pilar
    VIRAL IMMUNOLOGY, 2023, 36 (06) : 429 - 434
  • [12] Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018-2020
    Murhekar, Manoj, V
    Gupta, Nivedita
    Hasan, Alvira Z.
    Kumar, Muthusamy Santhosh
    Kumar, V. Saravana
    Prosperi, Christine
    Sapkal, Gajanan N.
    Thangaraj, Jeromie Wesley Vivian
    Kaduskar, Ojas
    Bhatt, Vaishali
    Deshpande, Gururaj Rao
    Thankappan, Ullas Padinjaremattathil
    Bansal, Avi Kumar
    Chauhan, Sanjay L.
    Grover, Gangandeep Singh
    Jain, Arun Kumar
    Kulkarni, Ragini N.
    Sharma, Santanu Kumar
    Chaaithanya, Itta K.
    Kharwal, Sanchit
    Mishra, Sunil K.
    Salvi, Neha R.
    Sharma, Sandeep
    Sarmah, Nilanju P.
    Sabarinathan, R.
    Duraiswamy, Augustine
    Rani, D. Sudha
    Kanagasabai, K.
    Lachyan, Abhishek
    Gawali, Poonam
    Kapoor, Mitali
    Shrivastava, Arpit Kumar
    Chonker, Saurabh Kumar
    Tilekar, Bipin
    Tandale, Babasaheb, V
    Ahmad, Mohammad
    Sangal, Lucky
    Winter, Amy
    Mehendale, Sanjay M.
    Moss, William J.
    Hayford, Kyla
    LANCET GLOBAL HEALTH, 2022, 10 (11): : E1655 - E1664
  • [13] Immunity against measles, mumps, rubella, and varicella among homeless individuals in Germany - A nationwide multi-center cross-sectional study
    Graf, Wiebke
    Bertram, Franziska
    Dost, Katharina
    Brennecke, Anna
    Kowalski, Veronika
    van Rueth, Victoria
    Noerz, Dominik Sebastian
    Wulff, Birgit
    Ondruschka, Benjamin
    Pueschel, Klaus
    Pfefferle, Susanne
    Luetgehetmann, Marc
    Heinrich, Fabian
    FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [14] Seroprevalence of pertussis among healthcare workers: A cross-sectional study from Tunisia
    Ben Fraj, Ikram
    Smaoui, Hanen
    Zghal, Maroua
    Sassi, Orjouane
    Guiso, Nicole
    Kechrid, Amel
    VACCINE, 2019, 37 (01) : 109 - 112
  • [15] Interpreting the Influence of Using Blood Donor Residual Samples for SARS-CoV-2 Seroprevalence Studies in Japan: Cross-Sectional Survey Study
    Kinoshita, Ryo
    Miyamoto, Sho
    Suzuki, Tadaki
    Suzuki, Motoi
    Yoneoka, Daisuke
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2025, 11
  • [16] Effectiveness of immunization activities on measles and rubella immunity among individuals in East Sepik, Papua New Guinea: A cross-sectional study
    Ichimura, Yasunori
    Yamauchi, Masato
    Yoshida, Naoko
    Miyano, Shinsuke
    Komada, Kenichi
    Thandar, Moe Moe
    Tiwara, Steven
    Mita, Toshihiro
    Hombhanje, Francis W.
    Mori, Yoshio
    Takeda, Makoto
    Hachiya, Masahiko
    IJID REGIONS, 2022, 3 : 84 - 88
  • [17] Increased measles and rubella seroprevalence in children using residual blood samples from health facilities and household serosurveys after supplementary immunization activities in two districts in India
    Prosperi, Christine
    Hasan, Alvira Z.
    Winter, Amy K.
    Chaaithanya, Itta Krishna
    Salvi, Neha R.
    Sharma, Sandeep
    Bansal, Avi Kumar
    Chauhan, Sanjay L.
    Kulkarni, Ragini N.
    Lachyan, Abhishek
    Gawali, Poonam
    Kapoor, Mitali
    Shrivastava, Arpit Kumar
    Chonker, Saurabh K.
    Bhatt, Vaishali
    Kaduskar, Ojas
    Deshpande, Gururaj Rao
    Esteban, Ignacio
    Sabarinathan, R.
    Saravana Kumar, Velusamy
    Truelove, Shaun A.
    Kumar, Muthusamy Santhosh
    Thangaraj, Jeromie W. Vivian
    Sangal, Lucky
    Mehendale, Sanjay M.
    Sapkal, Gajanan N.
    Gupta, Nivedita
    Hayford, Kyla
    Moss, William J.
    Murhekar, Manoj V.
    EPIDEMIOLOGY & INFECTION, 2024, 152
  • [18] Under-recognized pertussis in adults from Asian countries: a cross-sectional seroprevalence study in Malaysia, Taiwan and Thailand
    Koh, M. T.
    Liu, C. -S.
    Chiu, C. -H.
    Boonsawat, W.
    Watanaveeradej, V.
    Abdullah, N.
    Zhang, Xh.
    Devadiga, R.
    Chen, J.
    EPIDEMIOLOGY AND INFECTION, 2016, 144 (06) : 1192 - 1200
  • [19] Lessons from low seroprevalence of SARS-CoV-2 antibodies in schoolchildren: A cross-sectional study
    Szepfalusi, Zsolt
    Schmidthaler, Klara
    Sieber, Justyna
    Kopanja, Sonja
    Goetzinger, Florian
    Schoof, Anja
    Hoz, Jakub
    Willinger, Birgit
    Makristathis, Athanasios
    Weseslindtner, Lukas
    Stiasny, Karin
    Bohle, Barbara
    Krotka, Pavla
    Graf, Alexandra
    Frischer, Thomas
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2021, : 762 - 770
  • [20] Cross-sectional seroprevalence study of bovine herpesvirus 1, bovine respiratory syncytial virus, and parainfluenza virus 3 in cattle from Villavicencio, Colombia
    Gonzalez, Catalina Ballesteros
    Brinez, Karen
    Tobon, Julio Cesar
    Corredor, Danny Wilson Sanjuanelo
    Bauermann, Fernando Vicosa
    Barragan, Blanca Lisseth Guzman
    BMC VETERINARY RESEARCH, 2025, 21 (01)